載入...
MON-378 Efficacy and Safety of Romosozumab vs Alendronate Is Similar Across Different Levels of Renal Function Among Postmenopausal Women with Osteoporosis
Postmenopausal women with osteoporosis may also have renal insufficiency. We conducted a post hoc analysis of the ARCH study to determine the efficacy and safety of romosozumab (Romo) vs alendronate (ALN) among patients with different levels of baseline renal function. In ARCH, 4,093 postmenopausal...
Na minha lista:
| 發表在: | J Endocr Soc |
|---|---|
| Main Authors: | , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Oxford University Press
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7207955/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jendso/bvaa046.050 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|